Drugs & TargetsFree Cologuard gets FDA approval for use in younger patients indication September 27, 2019Vol.45 No.36
Drugs & TargetsFree Astellas gets CHMP nod for Xospata as monotherapy for an AML indication September 27, 2019Vol.45 No.36
Drugs & TargetsFree CHMP recommends approval for Bavencio + Axitinib for first-line treatment of advanced RCC September 27, 2019Vol.45 No.36
Drugs & TargetsFree Celsius Therapeutics brings genomics platform to three institutions worldwide September 27, 2019Vol.45 No.36
Drugs & TargetsFree Foundation Medicine, Natera to advance personalized cancer monitoring September 27, 2019Vol.45 No.36
Drugs & TargetsFree Adaptive Biotechnologies, Amgen use clonoSEQ as preferred MRD test September 27, 2019Vol.45 No.36
Drugs & Targets FDA approves Keytruda + Lenvima for advanced endometrial carcinoma September 20, 2019Vol.45 No.35
Drugs & Targets FDA approves Erleada for metastatic castration-sensitive prostate cancer September 20, 2019Vol.45 No.35
Drugs & Targets NCTN trials clinically meaningful and cost-effective, study finds September 20, 2019Vol.45 No.35
